Condition
Tumor, Solid clinical trials and research
As of November 12, 2026, Find a Trial lists 16 Tumor, Solid clinical trials that are recruiting, at sites in 6 countries (most in China (7), United States (6), South Korea (1)). By phase: Phase 1/2 (6), Phase 1 (6), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 16Clinical trials
- 6Countries
Newest Tumor, Solid clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Carbon nanoparticle‑loaded iron for advanced solid tumors | Phase 1/2 | Beijing, Beijing Municipality and 8 other locations | Recruiting | Feb 25, 2026 |
| RGL-270 vaccine alone or with adebelimab to lower risk of cancer coming back after surgery | Phase 1 | Shanghai | Recruiting | Jan 16, 2026 |
| Evaluating XNW29016 Tablets for Advanced Solid Tumors After Standard Treatment Failure | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | May 23, 2025 |
| Evaluating AD1208 for advanced solid tumors | Phase 1/2 | Seongnam-si, Gyeonggi-do and 2 other locations | Recruiting | Apr 4, 2025 |
| Nutritional management for children with solid tumors | — | Shanghai, Shanghai Municipality | Recruiting | Dec 12, 2024 |
| Treatment for advanced solid tumors using engineered T cells | Phase 1 | Tianjin, Tianjin Municipality | Recruiting | Jul 3, 2024 |
| T-cell therapy for patients with advanced solid tumors | Phase 1 | Wuhan, Hubei and 1 other locations | Recruiting | Jul 3, 2024 |
| Testing a new CAR T cell therapy for solid tumors | Phase 1/2 | London and 1 other locations | Recruiting | Jan 5, 2024 |
| Assessing immune profiles to predict responses to cancer immunotherapy | — | Lebanon, New Hampshire | Recruiting | Nov 3, 2023 |
| Monoclonal antibody treatment for advanced solid tumors | Phase 1/2 | Austin, Texas and 3 other locations | Recruiting | Oct 19, 2023 |
All recruiting trials (16)
-
Carbon nanoparticle‑loaded iron for advanced solid tumors
This test uses direct injections of a carbon nanoparticle‑loaded iron medicine (CNSI‑Fe) to see if it can shrink tumors in adults with advanced solid cancers who have no effective standard treatment options.
-
RGL-270 vaccine alone or with adebelimab to lower risk of cancer coming back after surgery
This phase I trial will test whether a personalized mRNA vaccine called RGL-270, given alone or with the immune drug adebelimab, can help prevent recurrence in adults who had radical treatment for high‑risk malignant solid tumors.
-
Evaluating XNW29016 Tablets for Advanced Solid Tumors After Standard Treatment Failure
This study is testing if XNW29016 tablets can help people with advanced solid tumors who haven't responded to regular treatments.
-
Evaluating AD1208 for advanced solid tumors
This study is testing a new drug called AD1208 to see if it is safe and tolerable for people with advanced solid tumors.
-
Nutritional management for children with solid tumors
This study is testing a new nutrition plan to see if it helps children with solid tumors get better nutrition and improve their health.
-
Treatment for advanced solid tumors using engineered T cells
This study is testing a new treatment using specially designed T cells to see if it can help people with advanced solid tumors that haven't responded to other therapies.
-
T-cell therapy for patients with advanced solid tumors
This study is testing a new T-cell therapy for patients with advanced solid tumors, like pancreatic and lung cancer, who haven't had success with other treatments to see if it can help them.
-
Testing a new CAR T cell therapy for solid tumors
This study is testing a new CAR T cell therapy called LEU011 to see if it is safe and effective for people with solid tumors.
-
Assessing immune profiles to predict responses to cancer immunotherapy
This study is testing if certain immune profiles can help predict how well cancer patients will respond to approved immunotherapy treatments.
-
Monoclonal antibody treatment for advanced solid tumors
This study is testing a new antibody treatment for people with advanced solid tumors to see if it is safe and effective on its own or when combined with another cancer drug.
-
Testing ONM-501 alone and with Cemiplimab for advanced solid tumors and lymphomas
This study is testing a new treatment called ONM-501, both alone and with another drug called cemiplimab, to see if it can help people with advanced solid tumors and lymphomas who have run out of other treatment options.
-
Radiotherapy for sinus carcinomas after surgery
This study tests whether a new type of targeted radiotherapy can help people with sinus cancer feel better after surgery compared to standard treatment.
-
Using TumorGlow for imaging solid tumors during surgery
This study is testing a special dye to see if it can help doctors see solid tumors better during surgery, so they can remove more cancer and improve patient outcomes.
-
INV-1120 alone and with pembrolizumab for adults with advanced solid tumors
This Phase 1 study will test whether the experimental drug INV-1120, given alone or with pembrolizumab, is safe and tolerable in adults with advanced solid tumors who have progressed after standard therapies.
-
Comparing two types of PET scans for cancer diagnosis
This study is testing whether a new type of PET scan can find cancer better than the standard scan in patients who have or might have tumors.
-
Combining ulixertinib and palbociclib for advanced pancreatic and solid tumors
This study is testing a new combination of two drugs, ulixertinib and palbociclib, to see if they can safely help adults with advanced solid tumors, including pancreatic cancer and melanoma, who haven't responded to other treatments.
Related topics
Quick answers
How many Tumor, Solid clinical trials are recruiting right now?
16, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in China (7 trials), United States (6 trials), South Korea (1 trial), United Kingdom (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 6, Phase 1: 6, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.